ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 151 filers reported holding ACHILLION PHARMACEUTICALS IN in Q4 2017. The put-call ratio across all filers is 1.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $35,000 | – | 12,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 11,733,815 | $81,081,000 | 11.64% |
| RTW INVESTMENTS, LP | 2,589,818 | $17,896,000 | 5.56% |
| DAFNA Capital Management LLC | 480,300 | $3,319,000 | 3.29% |
| DOHENY ASSET MANAGEMENT /CA | 510,125 | $3,525,000 | 1.83% |
| Sio Capital Management, LLC | 364,368 | $2,518,000 | 1.73% |
| TURNER INVESTMENTS LLC | 1,086,000 | $7,504,000 | 1.52% |
| Ghost Tree Capital, LLC | 300,000 | $2,073,000 | 0.93% |
| Rock Springs Capital Management LP | 1,125,000 | $7,774,000 | 0.63% |
| SENZAR ASSET MANAGEMENT, LLC | 619,000 | $4,277,290,000 | 0.62% |
| Point72 Asset Management, L.P. | 9,772,018 | $67,525,000 | 0.53% |